COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika)
Authors:
- Oliver PfaarOPOliver Pfaar
- Ludger KlimekLKLudger Klimek
- Eckard HamelmannEHEckard Hamelmann
- Jörg Kleine-TebbeJKJörg Kleine-Tebbe
- Christian TaubeCTChristian Taube
- Martin WagenmannMWMartin Wagenmann
- Thomas WerfelTWThomas Werfel
- Randolf BrehlerRBRandolf Brehler
- Natalija NovakNNNatalija Novak
- Sven BeckerSBSven Becker
- Margitta WormMWMargitta Worm
- 13 August 2021
- journal article
- research article
- Published by Springer Nature in Allergo Journal
- Vol. 30 (5) , 24-33
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- COVID-19: Pandemic Contingency Planning for the Allergy and Immunology ClinicThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPAAllergologie select, 2020
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesAnnals of the Rheumatic Diseases, 2020
- EUFOREA consensus on biologics for CRSwNP with or without asthmaAllergy, 2019
- Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudyArthritis Research & Therapy, 2019
- Impfen bei ImmundefizienzBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2019
- Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitisJournal of the American Academy of Dermatology, 2019
- Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trialJournal of Asthma and Allergy, 2018
- Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic childrenJournal of Allergy and Clinical Immunology, 2012